文献速递皮肤肿瘤

PRMT1抑制靶向BNC1依赖性鳞状细胞癌增殖

PRMT1 Inhibition Targets BNC1-Dependent Proliferation in Squamous Cell Carcinoma.
PubMed 文献 · J Invest Dermatol · 2025-09-15

本研究旨在发现维持鳞状细胞癌(SCC)肿瘤必需的转录复合物及其可靶向的催化活性。通过比较SCC与非SCC肿瘤表达谱,鉴定出SCC高表达的转录因子basonuclin 1(BNC1),其激活增殖基因并抑制FRA1依赖的促迁移程序和IRF6依赖的分化程序,且与PRMT1物理互作激活细胞周期基因。使用PRMT1抑制剂可阻断SCC肿瘤增殖,且不影响促迁移基因的抑制。

要点

  • BNC1是SCC特异性高表达转录因子,调控增殖-分化-迁移轴。
  • BNC1与PRMT1互作激活细胞周期基因,PRMT1抑制剂可阻断SCC增殖。
  • 抑制PRMT1不影响BNC1对促迁移基因的抑制,避免激活促进展通路。

核心结论

  • BNC1是SCC维持的关键转录因子,其与PRMT1互作激活增殖程序,抑制PRMT1可特异性阻断SCC增殖而不激活促迁移通路。

研究设计与样本

  • 本研究比较SCC肿瘤与非SCC肿瘤的表达模式,鉴定SCC特异性转录因子,并分析其直接转录靶标及与PRMT1的相互作用,使用PRMT1抑制剂处理SCC肿瘤。

主要发现

  • BNC1在SCC肿瘤中高表达,激活增殖基因并抑制FRA1依赖的促迁移程序和IRF6依赖的分化程序。
  • BNC1与PRMT1物理互作激活细胞周期基因,PRMT1抑制剂可阻断SCC肿瘤增殖。
  • PRMT1抑制剂不影响BNC1对促迁移基因的抑制。

临床怎么用

  • PRMT1抑制剂可能作为SCC靶向治疗策略,通过抑制BNC1-PRMT1互作阻断增殖而不激活促进展通路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Transcription factor complexes integrate diverse signals into discrete physiological outputs and are often aberrantly regulated in malignancies such as squamous cell carcinoma (SCC). In this study, we sought to discover new transcriptional complexes essential for SCC tumor maintenance, which have catalytic activities that can be targeted to provide new therapeutic options for patients with SCC. Comparing expression patterns of SCC tumors with those of non-SCC tumors, we have identified basonuclin 1 as a highly expressed, SCC-specific transcription factor. Analysis of direct transcriptional targets has uncovered an essential role for basonuclin 1 in controlling the proliferation-differentiation-migration axis. Basonuclin 1 activates proliferation genes while repressing a FRA1-dependent promigratory program and IRF6-dependent differentiation program. In addition, basonuclin 1 physically interacts with PRMT1 (protein arginine methyltransferase 1) to activate cell cycle genes. Importantly, proliferation can be blocked in SCC tumors using PRMT1 inhibitors, which has no effect on the repression of promigratory genes. Given the diverse gene expression programs regulated by transcription factors, this work demonstrates that protumorigenic activities can be specifically targeted through the inhibition of cofactors without activating pathways that may lead to tumor progression.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Boudra R, Patenall BL, King S, et al. PRMT1 Inhibition Targets BNC1-Dependent Proliferation in Squamous Cell Carcinoma. J Invest Dermatol. 2025. PMID: 40962202. doi:10.1016/j.jid.2025.08.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。